What happens when anyone can edit genes at home? We’re about to find out

Right now, for just $140, you can get your hands on one of the most powerful gene-editing tools known to science. You don’t even have to go out of your way, either. The ODIN do-it-yourself CRISPR kit, as it’s called, will ship it to your front door.

The project is the brainchild of ex-NASA scientist Josiah Zayner, who left the agency earlier this year to sell CRISPR kits from his Castro Valley, California apartment. After raising nearly $71,500 on Indiegogo, he turned to the ODIN full time.

People have a false sense of security about academic science being “good and safe”.

Zayner is one of an international community of biohackers who want to democratize science. Biology and the body are their playgrounds. They ask why experiments should be restricted to academic institutions and why sluggish processes of federal approval should stall scientific discoveries. Thanks to many biohackers, technologies that were once locked in the ivory tower are now available to practically anyone.

But many experts think Zayner’s efforts are careless and even dangerous. They worry about handing such powerful tools to a largely unregulated community of DIY scientists who lack the rigor and oversight of those at established institutions. They’re concerned that one man in a garage could inadvertently cause irreversible harm. And, although Zayner insists his intentions are good, some scientists wonder if it’s worth the risk.

CRISPR changes everything

To understand what Zayner does and why many experts object, let’s look at the revolutionary gene-editing “tool” called CRISPR-Cas9.

Here’s the short of it: the CRISPR system lets scientists edit DNA, delete and add specific genes to create specific mutations. It’s a remarkably precise, step-by-step technique that’s easy enough to be performed at home in a DIY lab. Using this tool, geneticists can edit stem cells in a petri dish, tweak genes inside fertilized eggs, or even target multiple genes at once, giving rise to drastically unique and designed DNA sequences.

For a longer explanation, check out this video from MIT:

As powerful as the tool is, at-home CRISPR experimentation isn’t federally regulated, unless those experiments are performed on regulated organisms like certain pathogens and stem cells. The government does, however, regulate the release of engineered organisms. So, you can toy around with CRISPR in your kitchen but you can’t distribute your creation without government approval.

With CRISPR, scientists have the potential to edit out genetic diseases, edit in immunities, and create transgenic species with relative ease. The ODIN’s CRISPR kits are designed to make much simpler mutations, such as adjusting the the color and scent of yeast — but that doesn’t necessarily calm nerves.

Risks at home and at the institution

“If you look at pathogenic organisms in nature, they often differ from their nonpathogenic counterparts by very tiny modifications,” Stuart Newman, Professor of Cell Biology and Anatomy at New York Medical College, tells Digital Trends. He points to the bacteria that causes the deadly diphtheria infection. “It was a benign resident of the respiratory system,” he says. “But at some point during evolution…it picked up a protein…which allowed the bacillus to interact with the human organism and cause horrendous illness.”

And the lab isn’t always safer than nature.

“I’m worried about the inadvertent side effects of well-intentioned uses.”

Fifteen years ago, an Australian research lab attempted to genetically engineer a contraceptive for mice as pest control. Instead, they accidentally modified a mild pox into a virus that killed every mouse it infected. And that was with much cruder gene-editing tools than those available today.

“We can’t predict these things ahead of time,” Newman says. “You can’t be sure you’re going to be dealing with a benign strain or gene. There are no rules for what’s going to be pathogenic and what’s not — something is only benign until you get a concoction that has an unexpected consequence.”

Zayner takes that point but doesn’t see scientific institutions as any more legitimately safe than DIY projects.

“The argument that at-home biohacking isn’t as safe or rigorous as academia is arbitrary,” Zayner says, adding that people have a false sense of security about academic science being “good and safe,” despite regular cock-ups. He cites a paper published last month that discovered an error in a common fMRI software. The study could invalidate some 40,000 scientific papers. “Over a decade of research under question because someone coded the software wrong,” he says.

If official authorization for CRISPR-like projects were confined to academic institutions or people with PhDs, Zayner thinks scientific progress would be stonewalled. “Even if these [DIY scientists] aren’t as skilled, how much quicker could we figure out issues with disease and understand the nature of the world we live in?”


However, this lack of skill is precisely one of Newman’s main concerns. He and Zayner are trained scientists, but the ODIN buyers may not be. There’s a scientific method, Newman says, and it must not be forgotten. “If you want to approach a scientific question, you have to have certain ideas in mind about what you want to study,” he says. “You’re not just tinkering. I don’t even know if I would call [DIY science] ‘science.’ It’s more like gaming.”

But, above all, Newman worries that provocative projects like those offered by the ODIN might undermine the gravity of the experiment.

The strains or genes in the ODIN kit are not regulated or inherently dangerous. Trained scientists have done the legwork to ensure that the CRISPR experiment results in specific, harmless outcomes. “But this gets it into people’s minds that it’s OK to genetically modify organisms — as a game or demonstration — and potentially release them into the environment,” Newman says. “And it’s not.”

Side effects may include…

Hank Greely leans back at his desk and looks up from his glasses with skepticism that falls somewhere between Zayner’s zeal for DIY science and Newman’s objection to it. The Director of Stanford’s Center for Law and the Biosciences admits, time and time again, that he isn’t against things like biohacking — he’s just nervous about it and thinks it must be regulated.

“Just because you can’t predict it perfectly doesn’t mean you shouldn’t try.”

“I’m worried about the malevolent uses,” Greely says. “I think we all are. But I’m also worried about the inadvertent side effects of well-intentioned uses.”

Everyone has E. Coli and although it’s often benign, there are dangerous strains. Scientists have mapped the genomes of both. Greely thinks it’s conceivable that a maleficent biohacker could obtain an E. coli sample — “Anyone with access to a toilet has access to a sample of E. coli.” — and make the necessary genetic modifications to turn that benign strain into a biological weapon. But that’s still pretty unlikely and would take some skill.

Instead, it’s the unbridled use of CRISPR that Greely thinks we should be most cautious about.

Zayner, meanwhile, estimates both of these risks are nominal. “It would take significant skill to turn this bacteria or yeast into a hazardous thing,” he says. And he likens the chance of accidentally creating a disruptive organism to the chance of accidentally making a bomb from computer parts.

Greely still isn’t sure. “New life forms are highly unpredictable in new environments,” he says, “which is partially an argument against my side because it means you can’t regulate it well, since you can’t predict it. But just because you can’t predict it perfectly doesn’t mean you shouldn’t try.”

What might regulation look like?

Greely offers a few starting points to consider for regulation. First, regulators need to know who’s conducting the experiments and how, so DIY scientists should need to register and follow safe lab practices, he says. If and when a new organism is engineered — no matter how seemingly benign — an expert should examine it to determine any potential risk. And regulators must have a plan to follow up and control the organism if things get out of hand. Consider a genetic “kill switch,” which can cause synthetic organisms to die in out-of-the-lab circumstances.

“It will be a tricky regulatory scheme but I think those are good starting points,” Greely says.

To be sure, Zayner isn’t anti-regulation. But, while the government takes its time weighing options, he intends to carry on with his experiments and help others do so, too. The ODIN currently consults on CRISPR projects for institutions like Princeton, the University of Washington, and the University of Chicago — Zayner and Newman’s alma mater.

“You know, we see science in the media and they say it will be out for public use in 20 years of something.,” he says. “That always disappointed me. I’m like, Fuck that man, I want to work with stuff now!

Emerging Tech

CRISPR gene therapy regulates hunger, staves off severe obesity in mice

Researchers from UC San Francisco have demonstrated how CRISPR gene editing can be used to prevent severe obesity in mice, without making a single edit to the mouse's genome. Here's how.
Emerging Tech

Postmates’ to roll out Minion-like autonomous delivery robots in 2019

Postmates is about to employ a cute little robot to work alongside its human delivery personnel. Called Serve, the wheel-based bot can carry items weighing up to 50 pounds and has a range of 30 miles.
Emerging Tech

The best drone photos from around the world

Most of today's drones come equipped with high-end cameras, which are quickly revolutionizing the world of aerial photography as we know it. Here are some of the best drone photos from around the world.
Emerging Tech

Are e-cigarettes safe? Here’s what the most recent science says

Ecigarettes are widely regarded and advertised as a healthier alternative to cigarettes for people who are trying to kick the smoking habit. How safe are these cigarette alternatives? We went deep into the recent scientific literature to…
Emerging Tech

Thrill-seekers will be able to pilot themselves in a giant drone as soon as 2019

Want to hitch a ride on a giant drone? The startup Lift Aircraft is gearing up to let paying customers fly its 18-rotor giant drones over assorted scenic landscapes across the U.S.
Emerging Tech

Capture app saves money by 3D scanning objects using iPhone’s TrueDepth camera

Capture is a new iPhone app created by the Y Combinator-backed startup Standard Cyborg. It allows anyone to perform 3D scans of objects and share them with buddies. Here's how it works.
Emerging Tech

Rise of the Machines: Here’s how much robots and A.I. progressed in 2018

2018 has generated no shortage of news, and the worlds of A.I. and robotics are no exception. Here are our picks for the most exciting, game changing examples of both we saw this year.
Emerging Tech

Sick of walking everywhere? Here are the best electric skateboards you can buy

Thanks for Kickstarter and Indiegogo, electric skateboards are carving a bigger niche than you might think. Whether you're into speed, mileage, or something a bit more stylish, here are the best electric skateboards on the market.
Emerging Tech

Parker Solar Probe captures first image from within the atmosphere of the sun

NASA has shared the first image from inside the atmosphere of the sun taken by the Parker Solar Probe. The probe made the closest ever approach to a star, gathering data which scientists have been interpreting and released this week.
Emerging Tech

Say cheese: InSight lander posts a selfie from the surface of Mars

NASA's InSight mission to Mars has commemorated its arrival by posting a selfie. The selfie is a composite of 11 different images which were taken by one of its instruments, the Instrument Deployment Camera.
Emerging Tech

Researchers create a flying wireless platform using bumblebees

Researchers at the University of Washington have come up with a novel way to create a wireless platform: using bumblebees. As mechanical drones' batteries run out too fast, the team made use of a biology-based solution using living insects.
Emerging Tech

Awesome Tech You Can’t Buy Yet: Booze-filled ski poles and crypto piggy banks

Check out our roundup of the best new crowdfunding projects and product announcements that hit the web this week. You may not be able to buy this stuff yet, but it sure is fun to gawk!
Emerging Tech

Bright ‘hyperactive’ comet should be visible in the sky this weekend

An unusual green comet, 46P/Wirtanen, will be visible in the night sky this month as it makes its closest approach to Earth in 20 years. It may even be possible to see the comet without a telescope.
Emerging Tech

Gorgeous images show storms and cloud formations in the atmosphere of Jupiter

NASA's Juno mission arrived at Jupiter in 2016 and has been collecting data since then. NASA has shared an update on the progress of the mission as it reaches its halfway point, releasing stunning images of the planet as seen from orbit.